Lubna Therachiyil

937 total citations · 1 hit paper
23 papers, 619 citations indexed

About

Lubna Therachiyil is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lubna Therachiyil has authored 23 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Lubna Therachiyil's work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer Cells and Metastasis (5 papers) and Epigenetics and DNA Methylation (3 papers). Lubna Therachiyil is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Cancer Cells and Metastasis (5 papers) and Epigenetics and DNA Methylation (3 papers). Lubna Therachiyil collaborates with scholars based in Qatar, United States and India. Lubna Therachiyil's co-authors include Shahab Uddin, Ajaz A. Bhat, Rashid Mir, Roopesh Krishnankutty, Mohammad Haris, Sheema Hashem, Sabah Nisar, Muzafar A. Macha, Sabah Akhtar and Hesham M. Korashy and has published in prestigious journals such as PLoS ONE, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Lubna Therachiyil

19 papers receiving 610 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents

2022 229 citations Sheema Hashem, Tayyiba Akbar Ali et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lubna Therachiyil Qatar	12	345	123	115	60	51	23	619
Alena Opattová Czechia	16	425 1.2×	186 1.5×	131 1.1×	86 1.4×	25 0.5×	25	758
Nina Xue China	18	508 1.5×	94 0.8×	143 1.2×	69 1.1×	30 0.6×	46	896
Veronica Cocetta Italy	13	317 0.9×	176 1.4×	98 0.9×	64 1.1×	47 0.9×	28	632
Baoping Jiang China	17	454 1.3×	145 1.2×	65 0.6×	67 1.1×	25 0.5×	33	852
Xia Lei China	12	289 0.8×	71 0.6×	140 1.2×	56 0.9×	36 0.7×	43	627
Jiawen Yu China	13	505 1.5×	104 0.8×	78 0.7×	40 0.7×	26 0.5×	27	819
Suresh R. Volate United States	10	383 1.1×	55 0.4×	86 0.7×	58 1.0×	46 0.9×	11	757
Bum‐Sang Shim South Korea	15	446 1.3×	107 0.9×	107 0.9×	142 2.4×	69 1.4×	39	926
Ying Hou China	17	441 1.3×	130 1.1×	77 0.7×	60 1.0×	19 0.4×	30	735
Fangtian Fan China	18	414 1.2×	192 1.6×	142 1.2×	36 0.6×	31 0.6×	44	760

Countries citing papers authored by Lubna Therachiyil

Since Specialization

Citations

This map shows the geographic impact of Lubna Therachiyil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lubna Therachiyil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lubna Therachiyil more than expected).

Fields of papers citing papers by Lubna Therachiyil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lubna Therachiyil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lubna Therachiyil. The network helps show where Lubna Therachiyil may publish in the future.

Co-authorship network of co-authors of Lubna Therachiyil

This figure shows the co-authorship network connecting the top 25 collaborators of Lubna Therachiyil. A scholar is included among the top collaborators of Lubna Therachiyil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lubna Therachiyil. Lubna Therachiyil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Therachiyil, Lubna, Ajaz A. Bhat, & Shahab Uddin. (2025). Claudins in ovarian cancer: emerging biomarkers and therapeutic targets. Tissue Barriers. 14(1). 2539026–2539026.

Prabhu, Kirti S., Lubna Therachiyil, Tariq Masoodi, Ajaz A. Bhat, & Shahab Uddin. (2025). GADD45: a crucial component of the DNA damage response and a potential cancer therapeutic target. Expert Opinion on Therapeutic Targets. 29(10). 743–756.

Therachiyil, Lubna, et al.. (2025). The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy. Journal of Experimental & Clinical Cancer Research. 44(1). 305–305. 1 indexed citations

Therachiyil, Lubna, et al.. (2025). SKP2 E3 ligase in urological malignancies: a critical regulator of the cell cycle and therapeutic target. Cell Cycle. 24(1-4). 1–15.

Therachiyil, Lubna, Paleerath Peerapen, Aamir Ahmad, et al.. (2024). Proteomic insight towards key modulating proteins regulated by the aryl hydrocarbon receptor involved in ovarian carcinogenesis and chemoresistance. Journal of Proteomics. 295. 105108–105108. 2 indexed citations

Therachiyil, Lubna, Zaid H. Maayah, Cristina Maccalli, et al.. (2024). Unlocking the secrets: exploring the influence of the aryl hydrocarbon receptor and microbiome on cancer development. Cellular & Molecular Biology Letters. 29(1). 33–33. 7 indexed citations

Therachiyil, Lubna, et al.. (2024). Inhibition of cytochrome P450 epoxygenase promotes endothelium-to-mesenchymal transition and exacerbates doxorubicin-induced cardiovascular toxicity. Molecular Biology Reports. 51(1). 859–859. 3 indexed citations

Therachiyil, Lubna, Hana Q. Sadida, Omar S. Khan, et al.. (2023). Epigenetic inhibitors and their role in cancer therapy. International review of cell and molecular biology. 380. 211–251. 4 indexed citations

Fernandes, Queenie, Lubna Therachiyil, Abdul Quaiyoom Khan, et al.. (2023). Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells. European Journal of Pharmaceutical Sciences. 191. 106586–106586. 16 indexed citations

10.

Therachiyil, Lubna, Joerg Buddenkotte, Majid Alam, et al.. (2023). Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma. International review of cell and molecular biology. 380. 149–171. 2 indexed citations

11.

Hashem, Sheema, Tayyiba Akbar Ali, Sabah Akhtar, et al.. (2022). Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomedicine & Pharmacotherapy. 150. 113054–113054. 229 indexed citations breakdown →

12.

Therachiyil, Lubna, et al.. (2022). Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways. Seminars in Cancer Biology. 86(Pt 3). 1186–1202. 14 indexed citations

13.

Therachiyil, Lubna, Roopesh Krishnankutty, Shahab Uddin, & Hesham M. Korashy. (2022). Aryl hydrocarbon Receptor (AhR) Promotes Cell Growth, Induces Stemness Like Characteristics and Metastasis in Ovarian Cancer Cells via Activation of Akt, β‐Catenin and EMT. The FASEB Journal. 36(S1). 2 indexed citations

14.

Akhtar, Sabah, Lubna Therachiyil, Abdullah Al‐Dhfyan, et al.. (2020). Epigenetic Regulation of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway. Seminars in Cancer Biology. 83. 177–196. 32 indexed citations

15.

Bhat, Ajaz A., Najeeb Syed, Lubna Therachiyil, et al.. (2020). Claudin-1, A Double-Edged Sword in Cancer. International Journal of Molecular Sciences. 21(2). 569–569. 103 indexed citations

16.

Therachiyil, Lubna, Kodappully Sivaraman Siveen, Shahab Uddin, et al.. (2020). Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin. Frontiers in Oncology. 10. 1744–1744. 18 indexed citations

17.

Prabhu, Kirti S., Afsheen Raza, Thasni Karedath, et al.. (2020). Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells. Cancers. 12(2). 351–351. 31 indexed citations

18.

Krishnankutty, Roopesh, Ahmad Iskandarani, Lubna Therachiyil, et al.. (2018). Anticancer Activity of Camel Milk via Induction of Autophagic Death in Human Colorectal and Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention. 19(12). 3501–3509. 47 indexed citations

19.

Prabhu, Kirti S., Kodappully Sivaraman Siveen, Shilpa Kuttikrishnan, et al.. (2017). Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells. PLoS ONE. 12(7). e0180895–e0180895. 35 indexed citations

20.

Bhat, Ajaz A., Kirti S. Prabhu, Shilpa Kuttikrishnan, et al.. (2016). Pristimerin Inhibits Growth and Induces Apoptosis in Human Colorectal Cancer Cells Through the Generation of Reactive Oxygen Species. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact